Sign in
Active, not recruitingNo phase

the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

Key facts

Who runs it
Lifetech Scientific (Shenzhen) Co., Ltd.
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
120 people, planned
Started
25 Jul 2021
Expected to end
30 Mar 2028
Type of study
Interventional
Treatments tested
  • the Aorta Arch Stent Graft System combined with the Endovascular Needle System
Record updated
23 July 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • 18 years old ≤age≤80 years old, no gender limitation
  • Diagnosis of aortic dissection and reconstruction of the left subclavian artery
  • The main branches and branches of the aortic arch at the lesion site have sufficient anatomical basis:; The diameter range of the near-end anchoring zone of the main body of the fixed mechanism: 21-46mm; The length of the anchor zone near the principal part of the tunnel is ≥10mm; The length of the anchor zone of the branching vessel of the convex target is ≥15mm; The diameter range of the distal anchoring zone of the target branching vessel is 5-18mm
  • The patient has adequate surgical access vessels
  • Patients who understand the purpose of the study, voluntarily participate in and sign informed consent, and are willing to follow up

Who cannot take part

  • The patient has been implanted or planned to be implanted with left ventricular auxiliary pump, interventional valve and other instruments, or is planning to undergo coronary intervention surgery, and aortic dissection is expected to affect the function of such instruments or such instruments will affect the operation of aortic dissection
  • Patients with a history of cerebral infarction or myocardial infarction within 3 months before surgery
  • The patient had a history of cardiac surgery (congenital heart disease surgery, heart valve surgery, coronary heart disease surgery, thoracic aortic surgery, etc.), which would affect the implementation of this TEVAR surgery
  • Marfan syndrome and other connective tissue diseases, arteritis
  • Patients with a history of allergy to contrast agents, anesthetics, antiplatelet drugs, anticoagulants, nickel peptide alloys, and polytetrafluoroethylene materials
  • Patients with active bleeding and coagulopathy
  • Patients with end-stage diseases with a life expectancy of less than one year
  • Abnormal renal function: patients with preoperative creatinine > 2.5 times the normal upper limit value
  • Abnormal liver function: patients with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 times the normal upper limit value, or patients with serum total bilirubin (STB) > 2 times the normal upper limit value
  • The patient is pregnant or breastfeeding
  • Patients with severe hematoma on the aortic wall in the proximal anchoring area of the stent
  • patients with poor compliance considered by the investigator
  • Patients participating in other clinical trials at the same time

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A prospective, multi-center, single-group target value method to evaluate the safety and effectiveness of the Aorta Arch Stent Graft System combined with the Endovascular Needle System in situ fenestration technology in the treatment of aortic dissection involving the aortic arch

The group in the trial

  • aortic dissection involving the aortic archTreatment being tested

    Aortic dissection involving the aortic arch was diagnosed in patients requiring revascularization of the aortic arch and its branches

    Treatment: the Aorta Arch Stent Graft System combined with the Endovascular Needle System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration Technology in the Treatment of Aortic Dissection Involving the Aortic Arch
Publications
Record updated
23 July 2024